News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
OncoMethylome Sciences S.A. in Deal for Brain Tumor Trial
April 16, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRUSSELS, April 16 (Reuters) - OncoMethylome Sciences SA begins MGMT gene promoter methylation testing in a recently started Phase III clinical trial for the U.S.-based, Radiotherapy Oncology Group in newly diagnosed brain tumors (glioblastoma).
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase III
Europe
MORE ON THIS TOPIC
Vaccines
Quick on Its Feet: Novavax Adapts to Continued Regulatory Uncertainty
June 20, 2025
·
3 min read
·
Heather McKenzie
Obesity
Scholar Rock Jumps on Weight Loss Data for Zepbound/Repurposed Antibody Combo
June 18, 2025
·
2 min read
·
Dan Samorodnitsky
Neuropsychiatric disorders
Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs
June 18, 2025
·
2 min read
·
Tristan Manalac
Approvals
CSL Wins First Approval for Preventive Hereditary Angioedema Drug
June 18, 2025
·
2 min read
·
Tristan Manalac